Xue Meng

6PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 19, 2026
Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II study.

|Mar 18, 2026
Low-dose intestinal irradiation enhances the efficacy and prognosis of PD-1 blockade in metastatic non-small cell lung cancer.

Baiyang Huang, Jiarui Zhao, Jingyu Zhu

|Sep 15, 2024
Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial.

Xiao Han, Jun Guo, Lingyu Li

|Apr 18, 2024
Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer.

Ying Fu, Qing Liu, Xiaohan Wang

|Feb 07, 2024
A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer.

Yanan Wang, Zhenhua Gao, Wen Zhao

|Nov 05, 2020
Timing of Adjuvant Chemoradiation in pT1-3N1-2 or pT4aN1 Esophageal Squamous Cell Carcinoma After R0 Esophagectomy.

Leilei Wu, Zhenshan Zhang, Shuo Li

Pageof 1

Frequent Collaborators

1 joint publications

Jisheng Li

1 joint publications

Xiao Han

1 joint publications

Baiyang Huang

1 joint publications

Jiarui Zhao